Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
PTC Therapeutics, Inc.
About PTCT
PTC Therapeutics, Inc. is a global biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. It has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD) a rare, life-threatening disorder. Its Upstaza, a gene therapy for the treatment of Aromatic L-Amino Decarboxylase (AADC) deficiency, a rare central nervous system (CNS) disorder. Its Tegsedi and Waylivra are for the treatment of rare diseases. Its Evrysdi, a treatment for spinal muscular atrophy (SMA).
Find out what a historical investment in PTC Therapeutics, Inc. would be worth today using our PTCT stock calculator.
Market Capitalisation
$5.93B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
843.49K
High today
$73.14
Low today
$71.34
Open price
$72.45
52-week high
$87.50
52-week low
$43.18
Ready to start your investing journey with Stake?
Open an accountHow do I buy PTCT shares in Australia?
Buying PTCT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in PTC Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PTCT
What is the ticker symbol of PTC Therapeutics, Inc.?
The ticker symbol for PTC Therapeutics, Inc. is PTCT.
How much is one share of PTCT?
One share of PTCT is valued at $71.74 as of 16 May 2026.
What is the market capitalisation of PTC Therapeutics, Inc. PTCT?
As of 16 May 2026 PTC Therapeutics, Inc. has a market cap of $5.93B.
What is the 52-week high for PTC Therapeutics, Inc. stock?
The PTC Therapeutics, Inc. 52-week high stock price is $87.50.
What is the 52-week low for PTC Therapeutics, Inc. stock?
The PTC Therapeutics, Inc. 52-week low stock price is $43.18.
Can I buy PTCT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PTCT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PTCT on Stake
- Buy PTCT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PTCT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PTCT related stocks